Company News

  • Reset
PharmaJet® to Highlight the Benefits of Intradermal Needle-free Delivery and Expansion into the Self-Injection Pen Market at Upcoming PODD Conference
GOLDEN, Colo. — October 21, 2025 — PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its needle-free injection technology, will present at the 15th Annual Partnership Opportunities in Drug Delivery (PODD) conference, October 27-28, at Westin Copley Place in Boston, Massachusetts. The conference brings
Tags: Events, Self-injector pen, Subcutaneous, Tropis
View
PharmaJet®, a World Leader in Needle-free Injection Systems, is Initiating the Development of Needle-free Self-Injection Pens for Home Use
GOLDEN, Colorado — October 7, 2025 — PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, today announced that it is expanding its needle-free injection portfolio with the development of a suite of proprietary, needle-free, self-injector pens. Prototypes of the
Tags: Disposable, Other, Self-injector pen, Subcutaneous
View